These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33738433)

  • 61. Manifestation of thrombocytopenia in dengue-2-virus-infected mice.
    Huang KJ; Li SJ; Chen SC; Liu HS; Lin YS; Yeh TM; Liu CC; Lei HY
    J Gen Virol; 2000 Sep; 81(Pt 9):2177-2182. PubMed ID: 10950974
    [TBL] [Abstract][Full Text] [Related]  

  • 62. First detection of dengue virus in the saliva of immunocompetent murine model.
    Rasinhas ADC; Silva MAND; Caldas GC; Jácome FC; Leonardo R; Santos FBD; Nunes PCG; Barth OM; Barreto-Vieira DF
    Mem Inst Oswaldo Cruz; 2018 Feb; 113(4):e170208. PubMed ID: 29412340
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Micro-anatomical changes in major blood vessel caused by dengue virus (serotype 2) infection.
    Priya SP; Sakinah S; Ling MP; Chee HY; Higuchi A; Hamat RA; Neela VK; Alarfaj AA; Munusamy MA; Hatamleh AA; Al-Sabri AE; Abdulaziz Al-Suwailem IA; Rajan M; Benelli G; Marlina ; Kumar SS
    Acta Trop; 2017 Jul; 171():213-219. PubMed ID: 28427958
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dengue transmission model by means of viremic adult immuno-competent mouse.
    Runtuwene LR; Konishi E; Yamanaka A; Makino Y; Suzuki Y; Takasaki T; Kurane I; Kobayashi T; Eshita Y
    Parasit Vectors; 2014 Mar; 7():143. PubMed ID: 24685121
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dengue encephalitis-associated immunopathology in the mouse model: Implications for vaccine developers and antigens inducer of cellular immune response.
    Marcos E; Lazo L; Gil L; Izquierdo A; Suzarte E; Valdés I; Blanco A; Ancizar J; Alba JS; Pérez Yde L; Cobas K; Romero Y; Guillén G; Guzmán MG; Hermida L
    Immunol Lett; 2016 Aug; 176():51-6. PubMed ID: 27233365
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Development of a humanized antibody with high therapeutic potential against dengue virus type 2.
    Li PC; Liao MY; Cheng PC; Liang JJ; Liu IJ; Chiu CY; Lin YL; Chang GJ; Wu HC
    PLoS Negl Trop Dis; 2012; 6(5):e1636. PubMed ID: 22563515
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cyclooxygenase-2 facilitates dengue virus replication and serves as a potential target for developing antiviral agents.
    Lin CK; Tseng CK; Wu YH; Liaw CC; Lin CY; Huang CH; Chen YH; Lee JC
    Sci Rep; 2017 Mar; 7():44701. PubMed ID: 28317866
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mechanisms of monocyte cell death triggered by dengue virus infection.
    Castillo JA; Urcuqui-Inchima S
    Apoptosis; 2018 Dec; 23(11-12):576-586. PubMed ID: 30267240
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Callithrix penicillata: a feasible experimental model for dengue virus infection.
    Ferreira MS; de Castro PH; Silva GA; Casseb SM; Dias Júnior AG; Rodrigues SG; Azevedo Rdo S; Costa e Silva MF; Zauli DA; Araújo MS; Béla SR; Teixeira-Carvalho A; Martins-Filho OA; Vasconcelos PF
    Immunol Lett; 2014; 158(1-2):126-33. PubMed ID: 24361035
    [TBL] [Abstract][Full Text] [Related]  

  • 70. IL-22 modulates IL-17A production and controls inflammation and tissue damage in experimental dengue infection.
    Guabiraba R; Besnard AG; Marques RE; Maillet I; Fagundes CT; Conceição TM; Rust NM; Charreau S; Paris I; Lecron JC; Renauld JC; Quesniaux V; Da Poian AT; Arruda LB; Souza DG; Ryffel B; Teixeira MM
    Eur J Immunol; 2013 Jun; 43(6):1529-44. PubMed ID: 23505056
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Monocyte recruitment to the dermis and differentiation to dendritic cells increases the targets for dengue virus replication.
    Schmid MA; Harris E
    PLoS Pathog; 2014 Dec; 10(12):e1004541. PubMed ID: 25474197
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection.
    Wang M; Yang F; Huang D; Huang Y; Zhang X; Wang C; Zhang S; Zhang R
    Front Cell Infect Microbiol; 2017; 7():157. PubMed ID: 28536674
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Vimentin Inhibits Dengue Virus Type 2 Invasion of the Blood-Brain Barrier.
    Yu J; Li X; Zhou D; Liu X; He X; Huang SH; Wu Q; Zhu L; Yu L; Yao J; Zhang B; Zhao W
    Front Cell Infect Microbiol; 2022; 12():868407. PubMed ID: 35433510
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Viperin is anti-viral
    Al Shujairi WH; Kris LP; van der Hoek K; Cowell E; Bracho-Granado G; Woodgate T; Beard MR; Carr JM
    J Gen Virol; 2021 Oct; 102(10):. PubMed ID: 34665110
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Virulence difference of five type I dengue viruses and the intrinsic molecular mechanism.
    Zou C; Huang C; Zhang J; Wu Q; Ni X; Sun J; Dai J
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007202. PubMed ID: 30830907
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Decreased peripheral dendritic cell numbers in dengue virus infection.
    De Carvalho Bittencourt M; Martial J; Cabié A; Thomas L; Césaire R
    J Clin Immunol; 2012 Feb; 32(1):161-72. PubMed ID: 21969208
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of continuous human B-cell epitopes in the envelope glycoprotein of dengue virus type 3 (DENV-3).
    da Silva AN; Nascimento EJ; Cordeiro MT; Gil LH; Abath FG; Montenegro SM; Marques ET
    PLoS One; 2009 Oct; 4(10):e7425. PubMed ID: 19826631
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mouse models of dengue virus infection for vaccine testing.
    Sarathy VV; Milligan GN; Bourne N; Barrett AD
    Vaccine; 2015 Dec; 33(50):7051-60. PubMed ID: 26478201
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine.
    Galula JU; Shen WF; Chuang ST; Chang GJ; Chao DY
    J Virol; 2014 Sep; 88(18):10813-30. PubMed ID: 25008922
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Celastrol inhibits dengue virus replication via up-regulating type I interferon and downstream interferon-stimulated responses.
    Yu JS; Tseng CK; Lin CK; Hsu YC; Wu YH; Hsieh CL; Lee JC
    Antiviral Res; 2017 Jan; 137():49-57. PubMed ID: 27847245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.